The Turn.io 2026 Health & AI Accelerator funds early-stage startups applying artificial intelligence to solve pressing health challenges, with a focus on scalable, evidence-based solutions that can improve patient outcomes or healthcare efficiency. It exists to bridge the gap between AI innovation and clinical impact, providing mentorship, networking, and potential funding to accelerate product-market fit in the health sector.

- Eligibility: Early-stage startup (pre-seed to Series A) with a working prototype or proof-of-concept in health and AI. - Innovation: Novelty of the AI approach and its potential to address an unmet medical need. - Technical feasibility: Sound methodology, validation data, and clear path to deployment. - Team: Founder or team with relevant domain expertise (e.g., pharma, ML) and commitment to full-time participation. - Impact: Scalability, potential for patient or healthcare system benefit, and alignment with health equity. - Business model: Clarity on go-to-market strategy, revenue model, and path to sustainability. - Fit with accelerator: Willingness to engage in structured mentorship, cohort activities, and milestone-based progress.

No specific past winners are listed on the provided page, but typical Turn.io accelerator cohorts include AI-driven diagnostics, digital therapeutics, and drug discovery platforms from diverse geographies. Archetypes include solo founders with deep domain expertise, teams with clinical validation, and startups leveraging large language models or computer vision for health applications.

The platonic ideal applicant is a pre-seed or seed-stage startup with a validated AI model addressing a clear health problem, a founder with both technical and domain expertise, early evidence of efficacy (e.g., benchmark results), and a realistic plan for clinical integration or partnership. The solution should be scalable, ethically sound, and ready to benefit from mentorship and network effects.